GlassScriptPhysician profile
Gerald Casas
NPI 1326157058
$8,138.80
in general payments reported to CMS, 2019-2025
30 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,836 · 2020: $1,698 · 2021: $452 · 2022: $611 · 2023: $1,034 · 2024: $351 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,393.60 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $960.13 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Coloplast Corp | $809.62 | 2019-2023 | Saffron, Altis |
| Astellas Pharma US INC | $415.62 | 2023-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $204.41 | 2019-2024 | Injectafer |
| Hologic Sales and Service, LLC | $158.04 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Femselect INC. | $156.67 | 2023 | Enplace |
| Mayne Pharma Commercial LLC | $146.74 | 2022-2025 | |
| Biom'Up France Sas | $118.60 | 2020 | |
| Merck Sharp & Dohme LLC | $110.91 | 2019-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $83.45 | 2020-2022 | |
| Coopersurgical, INC. | $75.70 | 2020-2025 | Ally II Ups |
| Pfizer INC. | $61.86 | 2022-2023 | |
| Lupin INC. | $60.10 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $53.33 | 2023-2024 | Myfembree |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $49.87 | 2021-2022 | |
| Avion Pharmaceuticals | $43.35 | 2019-2023 | Balcoltra |
| Momentis Surgical INC. | $29.00 | 2022 | |
| Conmed Corporation | $26.79 | 2023 | Conmed Specimen Retrieval, Airseal |
| Boston Scientific Corporation | $24.31 | 2023 | Solyx Sis System |
| Millicent US INC | $20.51 | 2025 | Femlyv |
| Mylan Pharmaceuticals INC. | $17.79 | 2022 | |
| Exeltis, USA INC. | $17.54 | 2024 | Slynd |
| Axonics, INC. | $16.23 | 2022 | |
| Caldera Medical, INC | $16.11 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.82 | 2019 | |
| Dysis Medical, INC. | $15.37 | 2021 | |
| Organon LLC | $15.12 | 2024 | |
| Agile Therapeutics, INC. | $11.15 | 2021 | |
| Covidien LP | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Casas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.